GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Synmosa Biopharma 4114.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

27.85

+2.39%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

7 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 0Strong buy
  • 0Buy
  • 3Hold
  • 1Sell
  • 3Strong sell

Forecasts

Analyst averages for the fiscal years ahead

FY2026
RevenueTWD 6.82bn
Revenue, highestTWD 6.82bn
Revenue, lowestTWD 6.82bn
Earnings per share1.68
Earnings per share, highest1.68
Earnings per share, lowest1.68
Analysts1

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026Q3 2025Q2 2025Q4 2024Q3 2024Q2 2024Q1 2024
Forecast0.410.410.640.600.480.520.440.36
Reported0.410.380.410.430.320.350.440.41
Difference+0.3%-6.7%-35.8%-28.0%-32.9%-32.4%0.0%+13.9%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

6 / 10

Revenue growth 13.3% a year over 10 years. Return on equity 9.4%.

Model fair value

31.39

From earnings 31.39, from revenue 29.24.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.